← Eichor
Condition: Protein Losing Enteropathy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Protein Losing Enteropathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Test the Safety of Pozelimab in Pediatric Participants 1 to 5 Years of Age With a Rare Disease Called CHAPLE
Phase 4 · 1 location(s) · Regeneron Pharmaceuticals · NCT07142343European Registry Study on Lymphatic Interventions
Phase N/A · 1 location(s) · Rigshospitalet, Denmark · NCT07131293A Prospective Natural History Study of Lymphatic Anomalies
Phase N/A · 2 location(s) · Eunice Kennedy Shriver National Institute of Child Health an · NCT05731141
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.